188 related articles for article (PubMed ID: 24753400)
1. Synthesis of a glycopeptide vaccine conjugate for induction of antibodies recognizing O-mannosyl glycopeptides.
Yu J; Westerlind U
Chembiochem; 2014 May; 15(7):939-45. PubMed ID: 24753400
[TBL] [Abstract][Full Text] [Related]
2. Induction of Antibodies Directed Against Branched Core O-Mannosyl Glycopeptides-Selectivity Complimentary to the ConA Lectin.
Yu J; Grant OC; Pett C; Strahl S; Stahl S; Woods RJ; Westerlind U
Chemistry; 2017 Mar; 23(14):3466-3473. PubMed ID: 28079948
[TBL] [Abstract][Full Text] [Related]
3. Microarray Analysis of Antibodies Induced with Synthetic Antitumor Vaccines: Specificity against Diverse Mucin Core Structures.
Pett C; Cai H; Liu J; Palitzsch B; Schorlemer M; Hartmann S; Stergiou N; Lu M; Kunz H; Schmitt E; Westerlind U
Chemistry; 2017 Mar; 23(16):3875-3884. PubMed ID: 27957769
[TBL] [Abstract][Full Text] [Related]
4. Conformational consequences of protein glycosylation: preparation of O-mannosyl serine and threonine building blocks, and their incorporation into glycopeptide sequences derived from alpha-dystroglycan.
Liu M; Borgert A; Barany G; Live D
Biopolymers; 2008; 90(3):358-68. PubMed ID: 17868094
[TBL] [Abstract][Full Text] [Related]
5. A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral immune response.
Dziadek S; Hobel A; Schmitt E; Kunz H
Angew Chem Int Ed Engl; 2005 Nov; 44(46):7630-5. PubMed ID: 16247815
[No Abstract] [Full Text] [Related]
6. Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and bovine serum albumin.
Dziadek S; Kowalczyk D; Kunz H
Angew Chem Int Ed Engl; 2005 Nov; 44(46):7624-30. PubMed ID: 16247814
[No Abstract] [Full Text] [Related]
7. Synthetic vaccines of tumor-associated glycopeptide antigens by immune-compatible thioether linkage to bovine serum albumin.
Wittrock S; Becker T; Kunz H
Angew Chem Int Ed Engl; 2007; 46(27):5226-30. PubMed ID: 17546719
[No Abstract] [Full Text] [Related]
8. Synthetic vaccines from tumor-associated glycopeptide antigens.
Westerlind U; Kunz H
Chimia (Aarau); 2011; 65(1-2):30-4. PubMed ID: 21469441
[TBL] [Abstract][Full Text] [Related]
9. Chemical synthesis of normal and transformed PSA glycopeptides.
Dudkin VY; Miller JS; Danishefsky SJ
J Am Chem Soc; 2004 Jan; 126(3):736-8. PubMed ID: 14733546
[TBL] [Abstract][Full Text] [Related]
10. Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
Cai H; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
Chemistry; 2011 May; 17(23):6396-406. PubMed ID: 21538615
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation in human thyroglobulin: location of the N-linked oligosaccharide units and comparison with bovine thyroglobulin.
Yang SX; Pollock HG; Rawitch AB
Arch Biochem Biophys; 1996 Mar; 327(1):61-70. PubMed ID: 8615697
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of fluorescein-labelled O-mannosylated peptides as components for synthetic vaccines: comparison of two synthetic strategies.
Brimble MA; Kowalczyk R; Harris PW; Dunbar PR; Muir VJ
Org Biomol Chem; 2008 Jan; 6(1):112-21. PubMed ID: 18075655
[TBL] [Abstract][Full Text] [Related]
13. Synthetic glycopeptides for the development of cancer vaccines.
Liakatos A; Kunz H
Curr Opin Mol Ther; 2007 Feb; 9(1):35-44. PubMed ID: 17330400
[TBL] [Abstract][Full Text] [Related]
14. Site-specific glycosylation analysis of the bovine lysosomal alpha-mannosidase.
Faid V; Evjen G; Tollersrud OK; Michalski JC; Morelle W
Glycobiology; 2006 May; 16(5):440-61. PubMed ID: 16449350
[TBL] [Abstract][Full Text] [Related]
15. Variation of the glycosylation pattern in MUC1 glycopeptide BSA vaccines and its influence on the immune response.
Cai H; Huang ZH; Shi L; Sun ZY; Zhao YF; Kunz H; Li YM
Angew Chem Int Ed Engl; 2012 Feb; 51(7):1719-23. PubMed ID: 22247051
[No Abstract] [Full Text] [Related]
16. Neurons and glia modify receptor protein-tyrosine phosphatase ζ (RPTPζ)/phosphacan with cell-specific O-mannosyl glycans in the developing brain.
Dwyer CA; Katoh T; Tiemeyer M; Matthews RT
J Biol Chem; 2015 Apr; 290(16):10256-73. PubMed ID: 25737452
[TBL] [Abstract][Full Text] [Related]
17. Preparation of glycosylated amino acids suitable for Fmoc solid-phase assembly.
Cudic M; Burstein GD
Methods Mol Biol; 2008; 494():187-208. PubMed ID: 18726575
[TBL] [Abstract][Full Text] [Related]
18. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
[TBL] [Abstract][Full Text] [Related]
19. Study of on-resin convergent synthesis of N-linked glycopeptides containing a large high mannose N-linked oligosaccharide.
Chen R; Tolbert TJ
J Am Chem Soc; 2010 Mar; 132(9):3211-6. PubMed ID: 20158247
[TBL] [Abstract][Full Text] [Related]
20. Glycopeptide and glycoprotein synthesis involving unprotected carbohydrate building blocks.
Guo Z; Shao N
Med Res Rev; 2005 Nov; 25(6):655-78. PubMed ID: 15895471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
